1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

doi:10.1083/jcb.98.2.391

This Article

	Full Text (PDF, 926K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Mangelsdorf, D. J.
	Articles by Haussler, M. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Mangelsdorf, D. J.
	Articles by Haussler, M. R.


Social Bookmarking

	What's this?

ARTICLES

1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

DJ Mangelsdorf, HP Koeffler, CA Donaldson, JW Pike and MR Haussler

The human-derived promyelocytic leukemia cell line, HL-60, is known to differentiate into mature myeloid cells in the presence of 1,25- dihydroxyvitamin D3 (1,25[OH]2D3). We investigated differentiation by monitoring 1,25(OH)2D3-exposed HL-60 cells for phagocytic activity, ability to reduce nitroblue tetrazolium, binding of the chemotaxin N- formyl-methionyl-leucyl-[3H]phenylalanine, development of nonspecific acid esterase activity, and morphological maturation of Wright-Giemsa- stained cells. 1,25(OH)2D3 concentrations as low as 10(-10) M caused significant development of phagocytosis, nitroblue tetrazolium reduction, and the emergence of differentiated myeloid cells that had morphological characteristics of both metamyelocytes and monocytes. These cells were conclusively identified as monocytes/macrophages based upon their adherence to the plastic flasks and their content of the macrophage-characteristic nonspecific acid esterase enzyme. The estimated ED50 for 1,25(OH)2D3-induced differentiation based upon nitroblue tetrazolium reduction and N-formyl-methionyl-leucyl- [3H]phenylalanine binding was 5.7 X 10(-9) M. HL-60 cells exhibited a complex growth response with various levels of 1,25(OH)2D3: less than or equal to 10(-10) M had no detectable effect, 10(-9) M stimulated growth, and greater than or equal to 10(-8) M sharply inhibited proliferation. We also detected and quantitated the specific receptor for 1,25(OH)2D3 in HL-60 and HL-60 Blast, a sub-clone resistant to the growth and differentiation effects of 1,25(OH)2D3. The receptor in both lines was characterized as a DNA-binding protein that migrated at 3.3S on high-salt sucrose gradients. Unequivocal identification was provided by selective dissociation of the 1,25(OH)2D3-receptor complex with the mercurial reagent, p-chloromercuribenzenesulfonic acid, and by a shift in its sedimentation position upon complexing with anti-receptor monoclonal antibody. On the basis of labeling of whole cells with 1,25(OH)2[3H]D3 in culture, we found that HL-60 contains approximately 4,000 1,25(OH)2D3 receptor molecules per cell, while the nonresponsive HL-60 Blast is endowed with approximately 8% of that number. The concentration of 1,25(OH)2D3 (5 X 10(-9) M) in complete culture medium, which facilitates the saturation of receptors in HL-60 cells, is virtually identical to the ED50 for the sterol's induction of differentiation. This correspondence, plus the resistance of the relatively receptor-poor HL-60 Blast, indicates that 1,25(OH)2D3- induced differentiation of HL-60 cells to monocytes/macrophages is occurring via receptor-mediated events.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Wang, J., Lian, H., Zhao, Y., Kauss, M. A., Spindel, S. (2008). Vitamin D3 Induces Autophagy of Human Myeloid Leukemia Cells. J. Biol. Chem. 283: 25596-25605 [Abstract] [Full Text]
Daftary, G. S., Taylor, H. S. (2006). Endocrine Regulation of HOX Genes. Endocr. Rev. 27: 331-355 [Abstract] [Full Text]
Savkur, R. S., Bramlett, K. S., Stayrook, K. R., Nagpal, S., Burris, T. P. (2005). Coactivation of the Human Vitamin D Receptor by the Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1 {alpha}. Mol. Pharmacol. 68: 511-517 [Abstract] [Full Text]
Adachi, R., Honma, Y., Masuno, H., Kawana, K., Shimomura, I., Yamada, S., Makishima, M. (2005). Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J. Lipid Res. 46: 46-57 [Abstract] [Full Text]
Bastie, J.-N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., Delva, L. (2004). 1{alpha},25-Dihydroxyvitamin D3 Transrepresses Retinoic Acid Transcriptional Activity via Vitamin D Receptor in Myeloid Cells. Mol. Endocrinol. 18: 2685-2699 [Abstract] [Full Text]
Albert, D. M., Kumar, A., Strugnell, S. A., Darjatmoko, S. R., Lokken, J. M., Lindstrom, M. J., Damico, C. M., Patel, S. (2004). Effectiveness of 1{alpha}-Hydroxyvitamin D2 in Inhibiting Tumor Growth in a Murine Transgenic Pigmented Ocular Tumor Model. Arch Ophthalmol 122: 1365-1369 [Abstract] [Full Text]
Pepper, C., Thomas, A., Hoy, T., Milligan, D., Bentley, P., Fegan, C. (2003). The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 101: 2454-2459 [Abstract] [Full Text]
Danilenko, M., Wang, Q., Wang, X., Levy, J., Sharoni, Y., Studzinski, G. P. (2003). Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium. Cancer Res. 63: 1325-1332 [Abstract] [Full Text]
Hofmann, W.-K., Koeffler, H. P. (2002). Differentiation Therapy for Myelodysplastic Syndrome. Clin. Cancer Res. 8: 939-941 [Full Text]
Bernardi, R. J., Trump, D. L., Yu, W.-D., McGuire, T. F., Hershberger, P. A., Johnson, C. S. (2001). Combination of 1{alpha},25-Dihydroxyvitamin D3 with Dexamethasone Enhances Cell Cycle Arrest and Apoptosis: Role of Nuclear Receptor Cross-Talk and Erk/Akt Signaling. Clin. Cancer Res. 7: 4164-4173 [Abstract] [Full Text]
Ward, J. O., McConnell, M. J., Carlile, G. W., Pandolfi, P. P., Licht, J. D., Freedman, L. P. (2001). The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor. Blood 98: 3290-3300 [Abstract] [Full Text]
Lazarova, D. L., Bordonaro, M., Sartorelli, A. C. (2001). Transcriptional Regulation of the Vitamin D3 Receptor Gene by ZEB. Cell Growth Differ. 12: 319-326 [Abstract] [Full Text]
Glorieux, G., Hsu, C., De Smet, R., Dhondt, A., van Emmelo, J., Waterloos, M.-A., Lameire, N., Plum, J., Vanholder, R. (2001). The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids. Nephrol Dial Transplant 16: 246-252 [Abstract] [Full Text]
Hutchinson, P. E., Osborne, J. E., Lear, J. T., Smith, A. G., Bowers, P. W., Morris, P. N., Jones, P. W., York, C., Strange, R. C., Fryer, A. A. (2000). Vitamin D Receptor Polymorphisms Are Associated with Altered Prognosis in Patients with Malignant Melanoma. Clin. Cancer Res. 6: 498-504 [Abstract] [Full Text]
Nishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y., Sono, H., Gon, Y., Yodoi, J. (1999). Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression. J. Biol. Chem. 274: 21645-21650 [Abstract] [Full Text]
Freedman, L. P. (1999). Transcriptional Targets of the Vitamin D3 Receptor�Mediating Cell Cycle Arrest and Differentiation. J. Nutr. 129: 581-581 [Abstract] [Full Text]
Simpson, R. U., O'Connell, T. D., Pan, Q., Newhouse, J., Somerman, M. J. (1998). Antisense Oligonucleotides Targeted against Protein Kinase Cbeta and Cbeta II Block 1,25-(OH)2D3-induced Differentiation. J. Biol. Chem. 273: 19587-19591 [Abstract] [Full Text]
Towers, T. L., Freedman, L. P. (1998). Granulocyte-Macrophage Colony-stimulating Factor Gene Transcription Is Directly Repressed by the Vitamin D3 Receptor. IMPLICATIONS FOR ALLOSTERIC INFLUENCES ON NUCLEAR RECEPTOR STRUCTURE AND FUNCTION BY A DNA ELEMENT. J. Biol. Chem. 273: 10338-10348 [Abstract] [Full Text]
Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., Sharma, S. (1998). Nuclear Factor of Activated T Cells (NFAT) as a Molecular Target for 1{alpha},25-Dihydroxyvitamin D3-Mediated Effects. J. Immunol. 160: 209-218 [Abstract] [Full Text]
Norman, A. W., Okamura, W. H., Hammond, M. W., Bishop, J. E., Dormanen, M. C., Bouillon, R., van Baelen, H., Ridall, A. L., Daane, E., Khoury, R., Farach-Carson, M. C. (1997). Comparison of 6-s-cis- and 6-s-trans-Locked Analogs of 1{alpha},25-Dihydroxyvitamin D3 Indicates That the 6-s-cis Conformation Is Preferred for Rapid Nongenomic Biological Responses and That Neither 6-s-cis- nor 6-s-trans-Locked Analogs Are Preferred for Genomic Biological Responses. Mol. Endocrinol. 11: 1518-1531 [Abstract] [Full Text]
He, R.-K., Gascon-Barré, M. (1997). Influence of the Vitamin D Status on the Early Hepatic Response to Carcinogen Exposure in Rats. J. Pharmacol. Exp. Ther. 281: 464-469 [Abstract] [Full Text]
Pichaud, F., Roux, S., Frendo, J.L., Delage-Mourroux, R., Maclouf, J., de Vernejoul, M.C., Moukhtar, M.S., Jullienne, A. (1997). 1,25-Dihydroxyvitamin D3 Induces NAD(+)-Dependent 15-Hydroxyprostaglandin Dehydrogenase in Human Neonatal Monocytes. Blood 89: 2105-2112 [Abstract] [Full Text]
Nakajima, S., Hsieh, J.-C., Jurutka, P. W., Galligan, M. A., Haussler, C. A., Whitfield, G. K., Haussler, M. R. (1996). Examination of the Potential Functional Role of Conserved Cysteine Residues in the Hormone Binding Domain of the Human 1,25-Dihydroxyvitamin D(3) Receptor. J. Biol. Chem. 271: 5143-5149 [Abstract] [Full Text]
Liu, M, Lee, M H, Cohen, M, Bommakanti, M, Freedman, L P (1996). Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.. Genes Dev. 10: 142-153 [Abstract]
Rehli, M., Krause, S. W., Kreutz, M., Andreesen, R. (1995). Carboxypeptidase M Is Identical to the MAX.1 Antigen and Its Expression Is Associated with Monocyte to Macrophage Differentiation. J. Biol. Chem. 270: 15644-15649 [Abstract] [Full Text]
Iiri, T., Homma, Y., Ohoka, Y., Robishaw, J. D., Katada, T., Bourne, H. R. (1995). Potentiation of G(i)-mediated Phospholipase C Activation by Retinoic Acid in HL-60 Cells. J. Biol. Chem. 270: 5901-5908 [Abstract] [Full Text]
Saulenas, A. M., Cohen, S. M., Key, L. L., Winter, C., Albert, D. M. (1988). Vitamin D and Retinoblastoma: The Presence of Receptors and Inhibition of Growth In Vitro. Arch Ophthalmol 106: 533-535 [Abstract]
McDonnell, D., Mangelsdorf, D., Pike, J., Haussler, M., O'Malley, B. (1987). Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235: 1214-1217 [Abstract]